The Medical Syringe Market in North America is expected to maintain a strong position through 2034, supported by the region’s advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of injection-based therapies. North America currently accounts for the highest revenue share of the global medical syringe market, according to The Insight Partners. The region benefits from the increasing prevalence of chronic diseases, expanding vaccination programs, growing use of biologic and biosimilar therapies, and continued improvements in medication-delivery technologies.

According to The Insight Partners, the global Medical Syringe Market size is projected to reach US$ 31.02 billion by 2034, rising from US$ 17.84 billion in 2025. The market is anticipated to register a CAGR of 6.34% during 2026–2034. The total addressable market is estimated to reach approximately US$ 221.09 billion during the forecast period, driven by the growing demand for reliable injection devices across preventive healthcare, chronic disease management, vaccination programs, emergency care, and specialized treatments.

The Medical Syringe Market represents a significant segment of the North American healthcare industry, with the United States serving as a key growth market. Market expansion is supported by the increasing prevalence of chronic diseases, the growing adoption of vaccination programs, advancements in needle-safety technologies, and evolving healthcare needs.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00018624

Medical Syringe Market Size, Share, Trends, Analysis, and Forecast to 2034

• Market Size, 2025: US$ 17.84 billion
• Market Size, 2034: US$ 31.02 billion
• CAGR, 2026–2034: 6.34%
• Total Addressable Market, 2026–2034: Approximately US$ 221.09 billion
• Leading Regional Market: North America
• Key Country Market: United States
• Forecast Period: 2026–2034
• Historical Data: 2021–2024
• Base Year: 2025

Medical Syringe Market Trends

Several trends are influencing the growth trajectory of the medical syringe industry. The increasing prevalence of diabetes, cardiovascular conditions, cancer, and other chronic diseases is generating sustained demand for injectable medications. The growing use of biologics and biosimilars is another important factor, as many advanced therapies require dependable injection and drug-delivery systems. The expansion of vaccination programs is further supporting demand across public and private healthcare facilities.

Another notable trend is the increasing adoption of safety syringes and retractable safety syringes. These products are designed to reduce accidental needlestick injuries and improve workplace safety for healthcare professionals. Prefilled syringes are also gaining attention because they can improve dosing convenience, reduce preparation steps, and support efficient drug administration. Meanwhile, the expansion of home healthcare is creating opportunities for syringes designed for simple and safe use outside traditional healthcare facilities.

Sustainability is emerging as another area of focus. Manufacturers are exploring ways to improve material efficiency and develop environmentally responsible syringe solutions while maintaining sterility, performance, and patient safety. Plastic and glass syringes continue to serve different applications, while advances in materials and manufacturing technologies are helping companies address evolving requirements.

Medical Syringe Market Analysis

The market is segmented according to usability, material, type, and geography. By usability, the market includes sterilizable/reusable syringes, hypodermic syringes, oral syringes, disposable syringes, conventional syringes, safety syringes, retractable safety syringes, non-retractable safety syringes, and prefilled syringes. By material, the market is divided into glass syringes and plastic syringes. By type, it includes general syringes, specialized syringes, insulin syringes, tuberculin syringes, allergy syringes, and other syringes such as catheter and angiographic syringes.

The growth of injectable therapies remains a major demand generator. As healthcare providers increasingly manage complex and chronic conditions, reliable delivery devices have become essential components of treatment. Furthermore, the continued development of targeted therapies and biologics is expected to create opportunities for specialized and prefilled syringe formats.

Regional Analysis

North America: North America holds the highest revenue share of the medical syringe market. The region benefits from sophisticated healthcare infrastructure, strong demand for advanced medical devices, increasing chronic disease prevalence, vaccination programs, and adoption of needle-safety technologies. The US, Canada, and Mexico are covered within the regional analysis.

Europe: Europe represents a significant market supported by established healthcare systems, demand for medical safety products, and increasing adoption of advanced drug-delivery technologies.

Asia-Pacific: Asia-Pacific is expected to register strong growth during the forecast period. Increasing healthcare expenditure, expanding healthcare infrastructure, growing patient populations, and rising demand for injectable treatments are contributing to regional opportunities. The report covers China, India, Japan, Australia, and other Asia-Pacific countries.

South and Central America: Increasing access to healthcare services and expanding medical infrastructure are supporting demand for essential injection devices.

Middle East and Africa: Growing healthcare investments and efforts to strengthen medical infrastructure are expected to create opportunities for syringe manufacturers across the region.

Key Players in the Medical Syringe Market

• Medtronic plc
• Smiths Medical
• Hindustan Syringes & Medical Devices Limited
• Gerresheimer AG
• SCHOTT AG
• CODAN Medizinische Geräte GmbH & Co KG
• Becton, Dickinson and Company
• Terumo Corporation
• B. Braun Medical Inc.
• NIPRO Corporation

These companies are contributing to industry development through product innovation, manufacturing expansion, safety-focused technologies, and the development of solutions for different clinical and drug-delivery applications.

Future Outlook

The outlook for the medical syringe industry remains positive through 2034. Increasing healthcare utilization, chronic disease management, vaccination initiatives, biologic therapies, and home-based treatment are expected to sustain demand. At the same time, manufacturers are likely to focus on safety, convenience, precision, sustainability, and compatibility with modern drug-delivery systems. Opportunities associated with the expansion of home healthcare, rising demand for biologics and biosimilars, and sustainable syringe solutions are expected to influence future industry dynamics.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish